トップ > 研究者情報 

昭和大学研究者情報・業績集

お問い合わせ

昭和大学図書館 業績集係

e-mail: 
achieve[at]lib.showa-u.ac.jp
(2019.07.04~変更)

tel:03-3784-8042
 

研究者情報

市川 度
ICHIKAWA Wataru
医学部内科学腫瘍内科学
藤が丘病院
教授
医学博士
腫瘍内科学
臨床薬理学、薬理遺伝子学
腫瘍学
No. ▽ 刊行年月 ▼ 業績項目 ▽ 著者 タイトル・書名 ▽ 雑誌名/学会・シンポジウム名 ▽ 巻 ▽ 号 ▽ 開始ページ ▽
1039810 2020-10 会議発表(論文・口頭) 島本 一志
戸村 和希
藤宮 龍祥
松井 美月
渡邊 徹
中山 博文
市川 度
佐々木 忠徳
がん患者におけるトラマドール鎮痛効果不十分に対する要因解析
第30回日本医療薬学会年会
1038863 2020-09 学術雑誌論文(学外) KUBOTA Yutaro
FUJITA Ken-ichi
TAKAHASHI Takehiro
SUNAKAWA Yu
ISHIDA Hiroo
HAMADA Kazuyuki
ICHIKAWA Wataru
TSUNODA Takuya
SHIMADA Kazuhiro
MASUO Yusuke
KATO Yukio
SASAKI Yasutsuna
Higher systemic exposure to unbound active metabolites of regorafenib is associated with short progression-free survival in colorectal cancer patients Clin Pharmacol Ther
108 3 586
1039809 2019-03 会議発表(論文・口頭) 島本 一志
田島 正教
杉山 恵理花
渡邊 徹
市川 度
佐藤 均
佐々木 忠徳
がん患者の皮膚角層水分量がフェンタニル貼付剤のフェンタニル残存率に及ぼす影響

日本臨床腫瘍薬学会学術大会2019
1033592 2018-12 学術雑誌論文(学外) SUNAKAWA Yu
SATAKE Hironaga
ICHIKAWA Wataru
Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors. World J Gastrointest Oncol
10 12 528
1033603 2018-12 学術雑誌論文(学外) SUNAKAWA Yu
YANG Dongyun
CAO Shu
ZHANG Wu
MORAN Miriana
ASTROW Stephanie H
HSIANG Jack
STEPHENS Craig
TSUJI Akihito
TAKAHASHI Takehiro
TANIOKA Hiroaki
NEGORO Yuji
TAKAGANE Akinori
TANI Satoshi
YAMAGUCHI Tatsuro
ETO Tetsuya
FUJII Masashi
ICHIKAWA Wataru
LENZ Heinz-Josef
Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal Cancer. Clin Colorectal Cancer
17 4 e741
1033595 2018-12 学術雑誌論文(学外) SUNAKAWA Yu
MOGUSHI Kaoru
LENZ Heinz-Josef
ZHANG Wu
TSUJI Akihito
TAKAHASHI Takehiro
DENDA Tadamichi
SHIMADA Ken
KOCHI Mitsugu
NAKAMURA Masato
KOTAKA Masahiro
SEGAWA Yoshihiko
TANIOKA Hiroaki
NEGORO Yuji
MORAN Miriana
ASTROW Stephanie H
HSIANG Jack
STEPHENS Craig
FUJII Masashi
ICHIKAWA Wataru
Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer. Mol Cancer Ther
17 12 2788
1038058 2018-04 学術雑誌論文(学外) SATAKE H
SUNAKAWA Y
MIYAMOTO Y
NAKAMURA M
NAKAYAMA H
SHIOZAWA M
MAKIYAMA A
KOBAYASHI K
KUBOTA Yutaro
MORI M
KOTAKA M
TAKAGANE A
GOTOH M
TAKEUCHI M
FUJII M
ICHIKAWA Wataru
SEKIKAWA Takashi
A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11. Oncotarget
9 27 18811
1033631 2017-12 学術雑誌論文(学外) SUNAKAWA Yu
TSUJI Akihito
DENDA Tadamichi
SEGAWA Yoshihiko
NEGORO Yuji
SHIMADA Ken
KOCHI Mitsugu
NAKAMURA Masato
KOTAKA Masahito
TANIOKA Hiroaki
TAKAGANE Akinori
TANI Satoshi
YAMAGUCHI Tatsuro
WATANABE Takanori
TAKEUCHI Masahiro
FUJII Masashi
ICHIKAWA Wataru
CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal Cancer. Target Oncol
12 6 787
1033615 2017-09 学術雑誌論文(学外) SUNAKAWA Yu
ICHIKAWA Wataru
TSUJI Akihito
DENDA Tadamichi
SEGAWA Yoshihiko
NEGORO Yuji
SHIMADA Ken
KOCHI Mitsugu
NAKAMURA Masato
KOTAKA Masahito
TANIOKA Hiroaki
TAKAGANE Akinori
TANI Satoshi
YAMAGUCHI Tatsuro
WATANABE Takanori
TAKEUCHI Masahiro
FUJII Masashi
NAKAJIMA Toshifusa
Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin-Based Chemotherapy: A Subgroup Analysis of the JACCRO CC-05/06 Trials. Clin Colorectal Cancer
16 3 e171
1033604 2017-08 学術雑誌論文(学外) SUNAKAWA Yu
TSUJI Atsuhito
FUJII Masakuni
ICHIKAWA Wataru
No benefit from the addition of anti-EGFR antibody in all right-sided metastatic colorectal cancer? Ann Oncol
28 8 2030
1023184 2016-11 学術雑誌論文(学外) TAKATA Kosuke
FUJITA Ken-ichi
KUBOTA Yutaro
ISHIDA Hiroo
ICHIKAWA Wataru
SHIMADA Ken
SEKIKAWA Takashi
TAKI-TAKEMOTO Iori
KAMEI Daisuke
IWAI Shinichi
SASAKI Yasutsuna
Cost-minimization analysis of adjuvant chemotherapy regimens given to patients with colorectal cancer in Japan. J Pharm Health Care Sci
2 30 1
1039058 2016-11 学術雑誌論文(学外) 今高 博美
関川 高志
市川 度
リスク予測研究 CPT-11の有害事象のリスク 日本臨牀
74 11 1847
1039035 2016-10 学術雑誌論文(学外) KAGA Yasuhiro
SUNAKAWA Yu
KUBOTA Yutaro
TAGAWA Teppei
YAMAMOTO Taikan
IKUSUE Toshikazu
UTO Yu
MIYASHITA Kouichirou
TOSHIMA Hirokazu
KOBAYASHI Kouji
HISAMATSU Atsushi
ICHIKAWA Wataru
SEKIKAWA Takashi
SHIMADA Ken
SASAKI Yasutsuna
Early tumor shrinkage as a predictor of favorable outcomes in patients with advanced pancreatic cancer treated with FOLFIRINOX Oncotarget
7 41 67314
1020021 2016-07 学術雑誌論文(学外) MATSUNAGA Mototsugu
KANETA Toshikado
MIWA Keisuke
ICHIKAWA Wataru
FUJITA Ken-ichi
NAGASHIMA Fumio
FURUSE Junji
KAGE Masayoshi
AKAGI Yoshito
SASAKI Yasutsuna
A comparison of four methods for detecting KRAS mutations in formalin-fixed specimens from metastatic colorectal cancer patients Oncol Lett
12 1 150
1033616 2016-07 学術雑誌論文(学外) SUNAKAWA Yu
YANG Dongyun
MORAN Miriana
ASTROW Stephanie H
TSUJI Akihito
STEPHENS Craig
ZHANG Wu
CAO Shu
TAKAHASHI Takehiro
DENDA Tadamichi
SHIMADA Ken
KOCHI Mitsugu
NAKAMURA Masato
KOTAKA Masahito
SEGAWA Yoshihiko
MASUISHI Toshiki
TAKEUCHI Masahiro
FUJII Masashi
NAKAJIMA Toshifusa
ICHIKAWA Wataru
LENZ Heinz-Josef
Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancer. Cancer Biol Ther
17 7 751
1016823 2015-10 会議発表(論文・口頭) 砂川 優
辻 晃仁
MORAN Miriana
ASTROW Stephanie H
ZHANG Wu
高橋 威洋
傳田 忠道
嶋田 顕
東風 貢
中村 将人
竹内 正弘
藤井 雅志
中島 聰總
LENZ Heinz-Josef
市川 度
大腸癌におけるcetuximab併用1次化学療法の臨床結果を予測するEGFR関連バイオマーカー
第53回日本癌治療学会学術集会
1015906 2015-09 学術雑誌論文(学外) ISHIDA Hiroo
ICHIKAWA Wataru
SASAKI Yasutsuna
Crizotinib-induced pancreatic pseudocyst: a novel adverse event. BMJ Case Rep
1
1021333 2015-08 学術雑誌論文(学外) SASAKI Yasutsuna
HAMADA Kazuyuki
KANETA Toshikado
TAKAHASHI Takehiro
KUBOTA Yutaro
ISHIDA Hiroo
ICHIKAWA Wataru
Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?
Cancer Sci
106 8 1100
1015015 2015-05 学術雑誌論文(学外) ICHIKAWA Wataru
UEHARA Keisuke
MINAMIMURA Keisuke
TANAKA Chihiro
TAKII Yasumasa
MIYAUCHI Hideaki
SADAHIRO Sotaro
FUJITA Ken-ichi
MORIWAKI Toshikazu
NAKAMURA Masato
TAKAHASHI Takehiro
TSUJI Akihito
SHINOZAKI Katsunori
MORITA Satoshi
ANDO Yuichi
OKUTANI Yukihiro
SUGIHARA Masahiro
SUGIYAMA Toru
OHASHI Yasuo
SAKATA Yuh
An internally and externally validated nomogram for predicting the risk of irinotecan-induced severe neutropenia in advanced colorectal cancer patients. Br J Cancer
112 10 1709
1021299 2015-04 学術雑誌論文(学外) MATSUYAMA Masato
ISHII Hiroshi
FURUSE Junji
OHKAWA Shinichi
MAGUCHI Hiroyuki
MIZUNO Nobumasa
YAMAGUCHI Taketo
IOKA Tatsuya
AJIKI Tetsuo
IKEDA Masafumi
HAKAMADA Kenichi
YAMAMOTO Masakazu
YAMAUE Hiroki
EGUCHI Kenji
ICHIKAWA Wataru
MIYAZAKI Masaru
OHASHI Yasuo
SASAKI Yasutsuna
Phase II trial of combination therapy of gemcitabine plus anti-angiogenic vaccination of elpamotide in patients with advanced or recurrent biliary tract cancer Invest New Drugs
33 2 490
1015022 2014-05 会議発表(論文・口頭) ICHIKAWA Wataru
UEHARA Keisuke
MINAMIMURA Keisuke
TANAKA Chihiro
TAKII Yasumasa
MIYAUCHI Hideaki
SADAHIRO Sotaro
FUJITA Ken-ichi
MORIWAKI Toshikazu
NAKAMURA Masato
TAKAHASHI Takehiro
TSUJI Akihito
SHINOZAKI Katsunori
MORITA Satoshi
ANDO Yuichi
OKUTANI Yukihiro
SUGIHARA Masahiro
SUGIYAMA Toru
OHASHI Yasuo
SAKATA Yuh
An internally and externally validated nomogram to predict severe neutropenia in Japanese patients (pts) with advanced colorectal cancer (aCRC) treated with irinotecan (IRI)-based regimens.
50th American Society of Clinical Oncology annual meeting
1015891 2013-10 学術雑誌論文(学外) SUNAKAWA Yu
TAKAHASHI Takehiro
ICHIKAWA Wataru
SHIMADA Ken
SASAKI Yasutsuna
Complicated puzzle in cetuximab-based chemotherapy: skin toxicity and resection rate in patients with initially unresectable colorectal liver metastases J Clin Oncol
31 35 4473

70282738